Detalhe da pesquisa
1.
The TGF-ß superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.
Immunity
; 54(2): 308-323.e6, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421362
2.
IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system.
Proc Natl Acad Sci U S A
; 120(26): e2221007120, 2023 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339207
3.
Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.
J Immunol
; 209(1): 49-56, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750335
4.
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
J Immunol
; 206(9): 2015-2028, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33820855
5.
IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
J Immunol
; 203(5): 1142-1150, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31341075
6.
IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.
Clin Immunol
; 197: 45-53, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30149119
7.
Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144].
Clin Immunol
; 237: 108967, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35307286
8.
IL-11 Induces Th17 Cell Responses in Patients with Early Relapsing-Remitting Multiple Sclerosis.
J Immunol
; 194(11): 5139-49, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25895532
9.
The role of endogenous IFN-ß in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis.
J Immunol
; 192(12): 5610-7, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24850724
10.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Clin Immunol
; 157(2): 121-32, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596452
11.
Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.
BMC Neurol
; 15: 232, 2015 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559139
12.
Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
J Immunol
; 191(12): 5867-74, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24198283
13.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Eur J Immunol
; 43(1): 281-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23076801
14.
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
Neurol Ther
; 13(2): 283-322, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206453
15.
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients.
bioRxiv
; 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260401
16.
Diffusion tensor imaging based network analysis detects alterations of neuroconnectivity in patients with clinically early relapsing-remitting multiple sclerosis.
Hum Brain Mapp
; 34(12): 3376-91, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22987661
17.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Ann Neurol
; 72(3): 385-94, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23034911
18.
Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.
J Immunol
; 187(6): 3431-7, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856936
19.
B cells as a therapeutic target for IFN-ß in relapsing-remitting multiple sclerosis.
J Immunol
; 186(7): 4518-26, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368231
20.
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
J Autoimmun
; 38(1): 10-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22123179